Literature DB >> 28271396

Intestinal absorption and buccal absorption of liquid levothyroxine.

Salvatore Benvenga1,2,3, Flavia Di Bari4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28271396     DOI: 10.1007/s12020-017-1250-4

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  18 in total

1.  TSH Normalization in Bariatric Surgery Patients After the Switch from L-Thyroxine in Tablet to an Oral Liquid Formulation.

Authors:  Poupak Fallahi; Silvia Martina Ferrari; Stefania Camastra; Ugo Politti; Ilaria Ruffilli; Roberto Vita; Giuseppe Navarra; Salvatore Benvenga; Alessandro Antonelli
Journal:  Obes Surg       Date:  2017-01       Impact factor: 4.129

2.  Understanding the oral mucosal absorption and resulting clinical pharmacokinetics of asenapine.

Authors:  Jeremy A Bartlett; Kees van der Voort Maarschalk
Journal:  AAPS PharmSciTech       Date:  2012-08-31       Impact factor: 3.246

3.  Treatment of hypothyroidism: all that glitters is gold?

Authors:  Anna Maria Formenti; Gherardo Mazziotti; Raffaele Giubbini; Andrea Giustina
Journal:  Endocrine       Date:  2016-02-29       Impact factor: 3.633

Review 4.  Levothyroxine absorption in health and disease, and new therapeutic perspectives.

Authors:  G Ianiro; F Mangiola; T A Di Rienzo; S Bibbò; F Franceschi; A V Greco; A Gasbarrini
Journal:  Eur Rev Med Pharmacol Sci       Date:  2014       Impact factor: 3.507

5.  A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations.

Authors:  Roberto Vita; Giovanna Saraceno; Francesco Trimarchi; Salvatore Benvenga
Journal:  Endocrine       Date:  2012-08-30       Impact factor: 3.633

6.  Celiac disease presenting as resistant hypothyroidism.

Authors:  J H McDermott; A Coss; C H Walsh
Journal:  Thyroid       Date:  2005-04       Impact factor: 6.568

7.  Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms.

Authors:  C S Yue; C Scarsi; M P Ducharme
Journal:  Arzneimittelforschung       Date:  2012-11-15

8.  The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis.

Authors:  Ane Garmendia Madariaga; Silvia Santos Palacios; Francisco Guillén-Grima; Juan C Galofré
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

9.  Necrotizing enterocolitis and hypothyroidism in a newborn infant: treatment with intravenous L-thyroxine.

Authors:  T Amer; R David; S E Oberfield
Journal:  Am J Perinatol       Date:  1994-01       Impact factor: 1.862

Review 10.  The administration of L-thyroxine as soft gel capsule or liquid solution.

Authors:  Roberto Vita; Poupak Fallahi; Alessandro Antonelli; Salvatore Benvenga
Journal:  Expert Opin Drug Deliv       Date:  2014-06-04       Impact factor: 6.648

View more
  3 in total

Review 1.  Novel thyroxine formulations: a further step toward precision medicine.

Authors:  Camilla Virili; Pierpaolo Trimboli; Marco Centanni
Journal:  Endocrine       Date:  2019-10-15       Impact factor: 3.633

2.  Liquid and softgel capsules of l-thyroxine results lower serum thyrotropin levels more than tablet formulations in hypothyroid patients.

Authors:  Salvatore Benvenga
Journal:  J Clin Transl Endocrinol       Date:  2019-08-06

Review 3.  Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults.

Authors:  Philippe Caron; Solange Grunenwald; Luca Persani; Françoise Borson-Chazot; Remy Leroy; Leonidas Duntas
Journal:  Rev Endocr Metab Disord       Date:  2021-10-20       Impact factor: 9.306

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.